FILTER

FILTERED INTERVIEW RESULTS

Chris Rector

VICE PRESIDENT – SOURCING AND SUPPLIER RELATIONS, CLARUSONE SOURCING SERVICES
Based in London, UK, ClarusONE Sourcing Services provides strategic services that allow McKesson Corporation and Walmart, Inc., to jointly source generic pharmaceuticals.

David H. Crean

MANAGING DIRECTOR, INVESTMENT BANKING, OBJECTIVE CAPITAL PARTNERS
Objective Capital Partners, headquartered in Southern California, is a leading mergers and acquisitions (M&A) investment banking firm focused on transactions for privately held companies with enterprise values up to US$500 million.

Vidya Vasu-Devan

DEPUTY DIRECTOR, BILL & MELINDA GATES FOUNDATION’S STRATEGIC INVESTMENT FUND
The Bill & Melinda Gates Foundation is the largest private foundation in the United States. Its Strategic Investment Fund (SIF) works to leverage the might of the private sector to achieve progress on the foundation’s charitable objectives.

Raul Rodriguez

PRESIDENT AND CEO, RIGEL
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and commercializing novel small molecule drugs for immune and hematologic disorders, cancer and rare diseases.

Elizabeth Jeffords

CHIEF COMMERCIAL & STRATEGY OFFICER, ALKAHEST
Alkahest has a unique technology platform for elucidating changes in the plasma proteome in healthy aging and in age-related diseases.

Michael Quirmbach

CHIEF BUSINESS OFFICER, CORDENPHARMA
CordenPharma is a CDMO supporting pharma and biotech companies, with cGMP facilities across Europe & the US.

Brian Frenzel

CEO, TOSK
Tosk is developing a family of small molecule drugs to prevent the toxic side ef-fects of cancer treatments.

Alan Seem

PARTNER, JONES DAY
Jones Day is the largest law firm in the United States and one of the ten largest firms globally.

David Craford

PRESIDENT AND CEO, CYTOBANK
Cytobank is developing and commercializing the leading SaaS platform for machine learning-based analysis of high-complexity life sciences data.

Paul Tanico

CEO, NEURODIAGNOSTICS LLC
NeuroDiagnostics is focused on its DISCERN™ test for the diagnosis of Alzheimer’s disease.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2022

PARTNER EVENTS